Bank Of America Corp Summit Therapeutics Inc. Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Bank Of America Corp holds 341,147 shares of SMMT stock, worth $7.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

341,147

Previous 390,343 12.6%

Holding current value

$7.47 Million

Previous $1.62 Million 64.6%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.39 - $10.92 $117,578 - $537,220	-49,196 Reduced 12.6%	341,147 $2.66 Million
Q1 2024 May 15, 2024	BUY	$2.55 - $5.07 $683,530 - $1.36 Million	268,051 Added 219.19%	390,343 $1.62 Million
Q4 2023 Feb 14, 2024	BUY	$1.67 - $2.83 $188,235 - $318,986	112,716 Added 1177.07%	122,292 $319,000
Q2 2023 Aug 14, 2023	SELL	$1.32 - $2.81 $8,910 - $18,967	-6,750 Reduced 41.35%	9,576 $24,000
Q1 2023 May 12, 2023	BUY	$1.38 - $5.41 $10,176 - $39,893	7,374 Added 82.37%	16,326 $28,000
Q4 2022 Feb 10, 2023	BUY	$0.68 - $5.31 $4,942 - $38,593	7,268 Added 431.59%	8,952 $38,000
Q3 2022 Nov 14, 2022	BUY	$0.89 - $1.63 $1,315 - $2,409	1,478 Added 717.48%	1,684 $2,000
Q2 2022 Aug 12, 2022	SELL	$0.92 - $2.38 $8,820 - $22,819	-9,588 Reduced 97.9%	206 $0
Q1 2022 May 16, 2022	SELL	$2.0 - $3.45 $19,034 - $32,833	-9,517 Reduced 49.28%	9,794 $24,000
Q4 2021 Feb 08, 2022	BUY	$2.45 - $5.64 $19,154 - $44,093	7,818 Added 68.02%	19,311 $52,000
Q3 2021 Nov 15, 2021	BUY	$4.83 - $8.27 $13,538 - $23,180	2,803 Added 32.26%	11,493 $57,000
Q2 2021 Sep 13, 2021	BUY	$5.15 - $8.46 $44,753 - $73,517	8,690 New	8,690 $65,000

Others Institutions Holding SMMT

# of Institutions

138

Shares Held

64.4M

Call Options Held

1.06M

Put Options Held

1.02M

View Full List

About Summit Therapeutics Inc.

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $4.41B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

More about SMMT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Summit Therapeutics Inc. Transaction History